ArticleLife science alliance2025
Integrative transcriptomic analysis reveals oligodendrocyte lineage switching in multiple sclerosis.
Article in Life science alliance, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Multiple sclerosis (MS) is a chronic disease of the central nervous system. The occurrence of MS is a phased process while its cause is still unclear. Here, by combining white matter single-nucleus transcriptomic datasets from MS and control samples, we found molecular crosstalk between oligodendrocytes (OLs) and immune cells involved in MS pathology. Using a machine learning approach, we identified oligodendrocyte precursor cells (OPCs) and OL subtypes at various developmental stages. We highlighted their unique molecular characteristics and analyzed their distribution throughout development, adulthood, and in different regions impacted by MS. We also found an increased number of Pre-OPCs and newly formed oligodendrocytes (NFOLs) in normal appearing white matter (NAWM), which were scarcely detected in MS lesions. By cell communication analysis and in vitro coculture, we found the interaction between SIRPA on microglia and CD47 on stressed oligodendrocytes was significantly reduced in MS lesions compared with NAWM, potentially preventing microglial phagocytosis of OLs. In contrast, CD74-MIF signaling between microglia and OLs was increased in lesions, which may lead to their retention around OLs.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.